Analysts delivered a mixed bag of rating changes on Tuesday, with downgrades hitting medical device maker COO and fintech giant INTU while healthcare and industrials names caught upgrades.
The Cooper Companies saw its consensus target price trimmed to $91.00 from $91.07. The contact lens maker carries 17 sell ratings against just one buy. Short interest sits at 2.8% of free float — modest, but the bearish analyst skew adds pressure.
Intuit suffered a target price cut to $505.31 from $509.82. The tax and accounting software group has no buy ratings from the 33 analysts covering it. Shares remain down this year after management flagged slowing SMB spending.
On the upgrade side, UnitedHealth Group received a target boost to $399.15. The insurer has been battered by fraud investigations and CEO turnover, yet bulls see value at current levels. Cadence Design Systems also gained a higher target at $383.94, with 22 buy ratings backing the EDA software firm.
Vertex Pharmaceuticals edged up to a $548.69 consensus target. Applied Materials and Philip Morris International both received modest target increases, reflecting steady earnings momentum in chips and tobacco respectively.
Darden Restaurants and Honeywell rounded out the upgrades, with analysts lifting both targets slightly as consumer spending data held firm.
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
